Abstract
Protein self-assembly is critical for numerous biological processes. Yet, assembly is rarely targeted by therapeutic agents, in part because it is hard to identify molecules that interfere with protein–protein interactions. Here, we describe a simple fluorescence-based screen for self-association and its application to the assembly of hepatitis B virus capsids. These data are analyzed to identify kinetic and thermodynamic effects—both of which are critical for the viral lifecycle and for understanding the mechanism of assembly effectors. Suggestions are made for modification of this protocol so that it can be applied to other self-assembling systems. With manual pipetting, setting up a plate takes about 2 h, the initial reading takes 1 h and the end point reading the following day takes about 5 min.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alberts, B. et al. Molecular Biology of the Cell (Garland Publishing, New York, 1994).
Strausberg, R.L. & Schreiber, S.L. From knowing to controlling: a path from genomics to drugs using small molecule probes. Science 300, 294–295 (2003).
Zlotnick, A. To build a virus capsid. An equilibrium model of the self assembly of polyhedral protein complexes. J. Mol. Biol. 241, 59–67 (1994).
Zlotnick, A., Ceres, P., Singh, S. & Johnson, J.M. A small molecule inhibits and misdirects assembly of hepatitis B virus capsids. J. Virol. 76, 4848–4854 (2002).
Prevelige, P.E.J. Inhibiting virus-capsid assembly by altering the polymerisation pathway. Trends Biotech. 16, 61–65 (1998).
Smith, T.J. et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233, 1286–1293 (1986).
Zhang, Y. et al. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. J. Virol. 78, 11061–11069 (2004).
Romero, J.R. Pleconaril: a novel antipicornaviral drug. Expert Opin. Investig. Drugs 10, 369–379 (2001).
Weber, O. et al. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. Antiviral Res. 54, 69–78 (2002).
Deres, K. et al. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299, 893–896 (2003).
Hacker, H.J., Deres, K., Mildenberger, M. & Schroder, C.H. Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion. Biochem. Pharmacol. 66, 2273–2279 (2003).
Stray, S.J. et al. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly. Proc. Natl. Acad. Sci. USA 102, 8138–8143 (2005).
Bourne, C., Finn, M.G. & Zlotnick, A. Global structural changes in hepatitis B capsids induced by the assembly effector HAP1. J. Virol. 80, 11055–11061 (2006).
Stray, S.J. & Zlotnick, A. BAY 41-4109 has multiple effects on hepatitis B virus capsid assembly. J. Mol. Recognit. 19, 542–548 (2006).
Stray, S.J., Johnson, J.M., Kopek, B.G. & Zlotnick, A. An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly. Nat. Biotechnol. 24, 358–362 (2006).
Ganem, D. & Schneider, R.J. Hepadnaviridae: The Viruses and Their Replication. 4th edn. (Lippincott Williams & Wilkins, Philadelphia, 2001).
Zhou, S. & Standring, D.N. Hepatitis B virus capsid particles are assembled from core-protein dimer precursors. Proc. Natl. Acad. Sci. USA 89, 10046–10050 (1992).
Crowther, R.A. et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77, 943–950 (1994).
Stannard, L.M. & Hodgkiss, M. Morphological irregularities in Dane particle cores. J. Gen. Virol. 45, 509–514 (1979).
Steven, A.C. et al. Structure, assembly, and antigenicity of hepatitis B virus capsid proteins. Adv. Virus Res. 64, 125–164 (2005).
Wynne, S.A., Crowther, R.A. & Leslie, A.G. The crystal structure of the human hepatitis B virus capsid. Mol. Cell 3, 771–780 (1999).
Dryden, K.A. et al. Native hepatitis B virions and capsids visualized by electron cryomicroscopy. Mol. Cell 22, 843–850 (2006).
Zlotnick, A., Johnson, J.M., Wingfield, P.W., Stahl, S.J. & Endres, D. A theoretical model successfully identifies features of hepatitis B virus capsid assembly. Biochemistry 38, 14644–14652 (1999).
Ceres, P. & Zlotnick, A. Weak protein-protein interactions are sufficient to drive assembly of hepatitis B virus capsids. Biochemistry 41, 11525–11531 (2002).
Zlotnick, A. Theoretical aspects of virus capsid assembly. J. Mol. Recognit. 18, 479–490 (2005).
Adolph, K.W. & Butler, P.J. Assembly of a spherical plant virus. Philos. Trans. R. Soc. Lond. B. 276, 113–122 (1976).
Prevelige, J., Thomas, D. & King, J. Scaffolding protein regulates the polymerization of P22 coat subunits into icosahedral shells in vitro . J. Mol. Biol. 202, 743–757 (1988).
Johnson, J.M. et al. Regulating self-assembly of spherical oligomers. Nano Lett. 5, 765–770 (2005).
Parent, K.N., Zlotnick, A. & Teschke, C.M. Quantitative analysis of multi-component spherical virus assembly: scaffolding protein contributes to the global stability of phage P22 procapsids. J. Mol. Biol. 359, 1097–1106 (2006).
Rapaport, D.C. Self-assembly of polyhedral shells: a molecular dynamics study. Phys. Rev. E. 70, 051905 (2004).
Hagan, M.F. & Chandler, D. Dynamic pathways for viral capsid assembly. Biophys. J. (2006).
Zhang, T. & Schwartz, R. Simulation study of the contribution of oligomer/oligomer binding to capsid assembly kinetics. Biophys. J. 90, 57–64 (2006).
Reddy, V.S. et al. Virus Particle Explorer (VIPER), a website for virus capsid structures and their computational analyses. J. Virol. 75, 11943–11947 (2001).
Riddles, P.W., Blakeley, R.L. & Zerner, B. Reassessment of Ellman's reagent. Methods Enzymol. 91, 49–60 (1983).
Bergstrom, F. et al. Dimers of dipyrrometheneboron difluoride (BODIPY) with light spectroscopic applications in chemistry and biology. J. Am. Chem. Soc. 124, 196–204 (2002).
Vogel, M., Diez, M., Eisfeld, J. & Nassal, M. In vitro assembly of mosaic hepatitis B virus capsid-like particles (CLPs): rescue into CLPs of assembly-deficient core protein fusions and FRET-suited CLPs. FEBS Lett. 579, 5211–5216 (2005).
Endres, D., Miyahara, M., Moisant, P. & Zlotnick, A. A reaction landscape identifies the intermediates critical for self-assembly of virus capsids and other polyhedral structures. Protein Sci. 14, 1518–1525 (2005).
van Holde, K.E., Johnson, W.C. & Ho, P.S. Principles of Physical Biochemistry. (Prentice-Hall, Upper Saddle River, New Jersey, 1998).
Pace, C.N., Vajdos, F., Fee, L., Grimsley, G. & Gray, T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4, 2411–2423 (1995).
Stray, S.J., Ceres, P. & Zlotnick, A. Zinc ions trigger conformational change and oligomerization of hepatitis B virus capsid protein. Biochemistry 43, 9989–9998 (2004).
Lakowicz, J.R. Principles of Fluorescence Spectroscopy. 2nd edn. (Kluwer Academic/Plenum Publishers, New York, 1999).
Ceres, P., Stray, S.J. & Zlotnick, A. Hepatitis B virus capsid assembly is enhanced by naturally occurring mutation F97L. J. Virol. 78, 9538–9543 (2004).
Acknowledgements
We thank Dr MG Finn and Dr Seijun Lee (TSRI) for the B compounds used to demonstrate the assay in this protocol. This work was supported by a grant from the National Institutes of Health (R01-AI 67417-01) to AZ and an American Cancer Society-Mary Horton post-doctoral fellowship (PF-05-237-01-GMC) to CRB.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors have applied for a patent for this assay.
Rights and permissions
About this article
Cite this article
Zlotnick, A., Lee, A., Bourne, C. et al. In vitro screening for molecules that affect virus capsid assembly (and other protein association reactions). Nat Protoc 2, 490–498 (2007). https://doi.org/10.1038/nprot.2007.60
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2007.60
This article is cited by
-
Asymmetrizing an icosahedral virus capsid by hierarchical assembly of subunits with designed asymmetry
Nature Communications (2021)
-
Allosteric conformational changes of human HBV core protein transform its assembly
Scientific Reports (2017)
-
Yield Optimisation of Hepatitis B Virus Core Particles in E. coli Expression System for Drug Delivery Applications
Scientific Reports (2017)
-
Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms
Scientific Reports (2017)
-
Drugs in Development for the Treatment of Chronic Hepatitis B
Current Hepatitis Reports (2012)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.